Catalent

Two businessmen pushing giant puzzle pieces together as the sun sets behind them
Biotech

CDMO Catalent strengthens ADC pipeline with $10M Lisata pact

Catalent has continued its foray into the ADC space, this time penning a $10 million biobucks pact to evaluate Lisata’s tumor drug.
James Waldron Oct 9, 2025 7:45am
duchenne muscular dystrophy

FDA skips AdComm for Sarepta's DMD therapy, sets decision date

Feb 28, 2023 8:00pm
3 three

Exelixis goes 3 in 3 with $30M for 3 Catalent programs

Nov 3, 2022 1:20pm
image of a few paragliders

Catalent shakes up leadership, taps new CEO—Chutes & Ladders

Jul 8, 2022 9:30am